|
|
|
|
|
|
Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a large-sized civilian-run public share holding and comprehensive medicine manufacturer in China, with the capacity of manufacturing 7 series medicines of more than 100 kinds and specifications including infusions, capsules, granules, tablets, oral liquids and etc. For the key product of large volume I.V solution, there are 6 GMP approved production lines with the yearly capacity of more than 150 million bottles in the dosage of 500 ml/ 250 ml /100ml. Both variety of the products and yearly output are in the leading position of this field in China.
To meet the global pharmaceutical market, the company has put a large amount of investment into the development of new medicines and techniques innovation. The I.V solution products and Chinese Traditional Herb medicines have become the 250 million main development directions of the company. In the latest years, Anti-brain Recession capsule, "SHANHE" oral liquid, Pentoxifylline and Sodium Chloride Injection, Inosine and Glucose Injection and Azithromycin Injection have put into market and get the consumers" recognition. The company insists on the ideal of "Quality first and human health uppermost" and has established the three-grade quality assurance system. The company operates under the GMP standard for the production and management to assure the whole production procedure supervised and the quality of the products. In recent ten years, the rate of qualified market samples is 100% inspected & tested by the National Pharmaceutical Supervision and Management Administration. By the end of 2001, all of the production of the products such as infusions, capsules, granules, tablets and etc. are GMP approved by China National Pharmaceutical Supervision and Management Administration.
|
|
|
| injection, solution, medica |
|
|
| Company : |
Shijiazhuang No.4 Pharmaceutical Co.,Ltd |
| Email: |
Contact us |
| URL: |
********
|
| Phone: |
*********
|
| Fax : |
*********
|
| Country : |
China |
| Address : |
*********
|
|
|
|
|
|
